Dyne Therapeutics :
DYN
DYN
Stock Data
$16.58
$0.13 (0.75%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Dyne Therapeutics Inc is a pioneering biotech firm based in Waltham, Massachusetts, dedicated to developing innovative treatments for a range of genetically driven muscle diseases. With a focus on conditions like myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, the company leverages its proprietary FORCE platform to create therapeutics aimed at modifying the course of these diseases. Founded in 2017, Dyne Therapeutics is at the forefront of addressing unmet needs in muscle disease treatment.
All Dyne Therapeutics Articles
66 Articles